Company Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Real-time Estimate Tradegate 05:32:17 2024-03-28 am EDT 5-day change 1st Jan Change
8.401 EUR +1.27% Intraday chart for Grifols, S.A. -0.69% -45.88%

Business Summary

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:

- products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries;

- diagnostic machines and reagents (14.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;

- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;

- other (5.4%): primarily intermediate biological products and subcontracted manufacturing services.

Net sales are distributed geographically as follows: Spain (5.3%), European Union (11.7%), the United States and Canada (63.6%) and other (19.4%).

Number of employees: 23,744

Sales per Business

EUR in Million2022Weight2023Weight Delta
Biopharma
84.3 %
5,005 82.5 % 5,558 84.3 % +11.05%
Diagnosis
10.2 %
671 11.1 % 670 10.2 % -0.15%
Others
3.1 %
250 4.1 % 203 3.1 % -18.67%
Bio Supplies
2.4 %
146 2.4 % 160 2.4 % +9.50%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States and Canada
59.1 %
3,856 63.6 % 3,899 59.1 % +1.12%
Rest of World
21.8 %
1,176 19.4 % 1,437 21.8 % +22.19%
Rest of European Union
13.5 %
712 11.7 % 893 13.5 % +25.50%
Spain
5.5 %
321 5.3 % 363 5.5 % +13.18%

Managers

Managers TitleAgeSince
Chief Executive Officer 65 06-04-04
Director of Finance/CFO 67 06-12-31
Chief Tech/Sci/R&D Officer - 03-12-31
55 -
Director/Board Member 48 16-05-29
Director/Board Member 61 01-07-26
Director/Board Member 68 00-04-12
Investor Relations Contact 61 95-12-31
Comptroller/Controller/Auditor 45 15-12-31
Human Resources Officer 58 21-06-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 65 06-04-04
Director/Board Member 68 00-04-12
Director/Board Member 61 01-07-26
Director/Board Member 59 15-05-28
Director/Board Member 56 15-05-28
Director/Board Member 61 20-10-08
Director/Board Member 48 16-05-29
Director/Board Member 55 Feb. 05
Director/Board Member 59 19-05-23
Director/Board Member 47 22-06-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 261,425,110 256,479,163 ( 98.11 %) 4,518,199 ( 1.728 %) 94.98 %
Stock B 1 426,129,798 396,559,176 ( 93.06 %) 3,944,430 ( 0.9256 %)

Shareholders

NameEquities%Valuation
39,183,692 9.195 % 322 M €
Scranton Enterprises BV
8.404 %
35,812,622 8.404 % 294 M €
30,209,093 7.089 % 248 M €
Ralledor Holding Spain SL
6.008 %
25,603,674 6.008 % 210 M €
BNP Paribas Asset Management Europe SAS
1.966 %
8,378,309 1.966 % 69 M €
Capital Research & Management Co. (World Investors)
1.899 %
8,092,817 1.899 % 66 M €
Caixabank Asset Management SGIIC SA
1.340 %
5,710,858 1.340 % 47 M €
Bestinver Gestión SA SGIIC
0.8807 %
3,752,897 0.8807 % 31 M €
BNP Paribas Asset Management Belgium SA
0.6132 %
2,613,106 0.6132 % 21 M €
AG2R LA MONDIALE GESTION d'ACTIFS SA
0.6007 %
2,559,757 0.6007 % 21 M €
NameEquities%Valuation
Brandes Investment Partners LP
5.156 %
13,480,174 5.156 % 75 M €
HSBC Global Asset Management (France) SA
0.5823 %
1,522,300 0.5823 % 8 M €
SIA Funds AG
0.2799 %
731,761 0.2799 % 4 M €
Oddo BHF Asset Management SAS
0.2664 %
696,476 0.2664 % 4 M €
Devon Equity Management Ltd.
0.2618 %
684,481 0.2618 % 4 M €
Santander Private Banking Gestion SA SGIIC
0.2471 %
646,013 0.2471 % 4 M €
DNCA Finance SA
0.2054 %
536,996 0.2054 % 3 M €
Gescooperativo SA SGIIC
0.1699 %
444,201 0.1699 % 2 M €
GVC Gaesco Gestión SGIIC SA
0.1684 %
440,306 0.1684 % 2 M €
Popular Asset Management SGIIC SA
0.1575 %
411,639 0.1575 % 2 M €
NameEquities%Valuation
Capital Research & Management Co. (World Investors)
7.569 %
19,787,525 7.569 % 149 M €
Millennium Management LLC
6.021 %
15,739,163 6.021 % 118 M €
Brandes Investment Partners LP
5.378 %
14,059,501 5.378 % 106 M €
Brandes Investment Partners LP
5.170 %
13,516,011 5.170 % 102 M €
Black Creek Investment Management, Inc.
3.539 %
9,251,618 3.539 % 69 M €
Flat Footed LLC
2.815 %
7,358,779 2.815 % 55 M €
Pictet Asset Management Holding SA
2.741 %
7,165,673 2.741 % 54 M €
First Trust Advisors LP
1.792 %
4,684,749 1.792 % 35 M €
Capital Research & Management Co. (Global Investors)
1.657 %
4,331,222 1.657 % 33 M €
Merrill Lynch International
1.610 %
4,207,933 1.610 % 32 M €
NameEquities%Valuation
Yousif Capital Management LLC
0.001549 %
13,202 0.001549 % 54 181 €
DSM Capital Partners LLC
0.000481 %
4,096 0.000481 % 16 810 €

Holdings

NameEquities%Valuation
437,069,656 6.49% 437,480,501 $

Company contact information

Grifols SA

Avinguda de la Generalitat, 152-158 Parc de Negocis Can Sant Joan

08174, Barcelona

+34 935 712 200

http://www.grifols.com
address Grifols, S.A.(GRF)

Group companies

NameCategory and Sector
Financial Conglomerates
Grifols India Healthcare Pvt Ltd.

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
8.296 EUR
Average target price
18.76 EUR
Spread / Average Target
+126.17%
Consensus